IJCRRI Journ Cur Res ReInternational Journal of Current Research and ReviewI Journ Cur Res Re2231-21960975-5241Radiance Research Academy4325http://dx.doi.org/10.31782/IJCRR.2022.14211HealthcareA Prospective Study of Risk Malignancy Index in Adnexal Masses KumariNehaSinghMamta16012022)5459This article is copyright of Popeye Publishing, 20092009This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.

This scoring system is based on serum CA-125, menopausal status, ultrasonographicfinding. This scoring method yield much better results than individual parameters. Methods: Present study conducted between July 2017 to June 2019.Parameter like menopausal status, ultrasoundfeatures, and serum level of tumor marker like CA-125 for calculating RMI 3. Then RMI was compared with the histopathological report which was taken as gold standard. Results: RMI 3 had a sensitivity of 100%, a specificity of 91.67%, a positive predictive value of 97.50% and negative predictive value of 100%. Conclusions: This scoring system due to its simplicity and applicability can be used by the general gynaecologists at the periphery to refer suspected ovarian cancer to oncologicalcenters and thereby improving the survival and prognosis of women undergoing surgery for ovarian tumors.

Adnexalmass Benign ovarian tumor CA-125 Malignantovarian tumor Menopausalstatus Risk Malignancy Index